[1]
|
2011 Alzheimer’s Disease Facts and Figures.
http://www.alz.org/downloads/Facts_Figures_2011.pdf
|
[2]
|
Alzheimer’s Association, Generation Alzheimer’s: The Defining Disease of the Baby Boomers.
http://act.alz.org/site/DocServer/ALZ_BoomersReport.pdf?docID=521
|
[3]
|
Fagan, A., Xiong, C. and Bateman, R., et al. (2011) Plasma and cerebrospinal fluid markers in the DIAN study of autosomal-dominant Alzheimer’s disease. Journal of Alz heimer’s & Dementia, 7, S287.
http://www.alzheimersanddementia.com/article/S1552-5260(11)00972-1/fulltext
|
[4]
|
Perrin, R.J., Craig-Schapiro, R. and Morris, J.C., et al. (2011) Identification and validation of novelcerebrospinal fluid biomarkers for staging early Alzheimer’s disease. PLoS One, 12, e16032.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3020224/?tool=pmcentrez
|
[5]
|
Torack, R.M. (1979) Adult dementia: History, biopsy, pathology. Neurosurgery, 4, 434-442.
doi:10.1227/00006123-197905000-00011
|
[6]
|
Blacker, D., Albert, M.S., Bassett, S.S., Go, R.C., Harrell, L.E. and Folstein, M.F. (1994) Reliability and validity of NINCDS-ADRDA criteria for Alzheimer’s disease. The National Institute of Mental Health Genetics Initiative. Archives of Neurology, 51, 1198-2204.
http://www.ncbi.nlm.nih.gov/pubmed/7986174?dopt=Abstract
|
[7]
|
Corey-Bloom, J., Thal, L. and Galasko, D., et al. (1995) Diagnosis and evaluation of dementia. Neurology, 45, 211-218. http://www.ncbi.nlm.nih.gov/pubmed/7854514
|
[8]
|
Tiraboschi, P., Hansen, L.A., Thal, L.J. and Corey-Bloom, J. (2004) The importance of neuritic plaques and tangles to the development and evolution of AD. Neurology, 8, 1984-1989. http://www.ncbi.nlm.nih.gov/pubmed/15184601?dopt=Abstract
|
[9]
|
Morris, J.C. (1993) The clinical dementia rating (CDR): Current version and scoring rules. Neurology, 11, 2412- 2414. http://www.ncbi.nlm.nih.gov/pubmed/8232972
|
[10]
|
Folstein, M.F., Folstein, S.E. and McHugh, P.R. (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
http://www.ncbi.nlm.nih.gov/pubmed/1202204
|
[11]
|
Jack, C.R., Bentley, M.D., Twomey, C.K. and Zinsmeister, A.R. (1990) MR Imaging-based volume measurements of the hippocampal formation and anterior temporal lobe: Validation studies. Radiology, 176, 205-209.
http://www.ncbi.nlm.nih.gov/pubmed/2353093
|
[12]
|
Jack, C.R., Petersen, R.C. and Xu, Y.C., et al. (1997) Medial temporal atrophy on MRI in normal aging and very mild Alzheimer’s disease. Neurology, 49, 786-794.
http://www.ncbi.nlm.nih.gov/pubmed/9305341
|
[13]
|
Saykin, A.J., Wishart, H.A. and Rabin, L.A., et al. (2006) Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI. Neurology, 12, 834-842. http://www.ncbi.nlm.nih.gov/pubmed/16966547
|
[14]
|
Small, B.J., Gagnon, E. and Robinson, B. (2007) Early identification of cognitive deficits: Preclinical Alzheimer’s disease and mild cognitive impairment. Geriatrics, 62, 19-23.
http://www.ncbi.nlm.nih.gov/pubmed/17408315
|
[15]
|
Waldemar, G., Dubois, B. and Emre, M., et al. (2007) Recommendations for the diagnosis and management of Alzheimer’s disease and other disorders associated with dementia: EFNS guideline. European Journal of Neurology, 14, e1-e26.
http://www.ncbi.nlm.nih.gov/pubmed/17222085
|
[16]
|
Maksimovich, I.V. and Gotman, L.N. (2006) Method of complex radiation diagnostics at preclinical and clinical stages of Alzheimer’s disease. Russian Patent No. 2315559. http://bankpatentov.ru/node/28577
|
[17]
|
Maksimovich, I.V., Gotman, L.N. and Masyuk, S.M. (2006) Method of determining dimensions of temporal brain lobes in patients suffering from Alzheimer’s disease. Russian Patent No. 2306102.
http://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&adjacent=true&locale=en_EP&FT=D&date=20070920&CC=RU&NR=2306102C1&KC=C1
|
[18]
|
Maksimovich, I.V. (2008) Radiodiagnostics of Alzheimer’s disease. Diagnostics and Intervention Radiology, 2, 27-38. http://www.radiology-di.ru/tom-2-N4-2008.html
|
[19]
|
Maksimovich, I.V. (2009) Possibilities of modern computed tomography of brain in Alzheimer’s disease diagnosis. The Neurologic Bulletin, 1, 5-10.
http://www.infamed.com/nb/1_2009_5-10.pdf
|
[20]
|
Chiang, G.C. Insel, Ph.S., Tosun, D., Schuff, N., Truran- Sacrey, D., Raptentsetsang, S., Jack, C.R. and Weiner, M.W. (2011) Identifying cognitively healthy elderly individuals with subsequent memory decline by using automated MR temporoparietal volumes. Radiology, 259, 844-851. http://radiology.rsna.org/content/259/3/844
|
[21]
|
Trojanowski, J.Q., Vandeerstichele, H. and Korecka, M., et al. (2010) Update on the biomarker core of the Alzheimer’s disease neuroimaging initiative subjects. Journal of Alzheimer’s & Dementia, 6, 230-238.
http://www.ncbi.nlm.nih.gov/pubmed/20451871
|
[22]
|
Jack, C., Vemuri, P.H. and Viste, H., et al. (2011) Ordering of Alzheimer’s disease biomarkers. Alzheimer’s & Dementia, 7, S4-S5. doi:10.1016/j.jalz.2011.05.011
|
[23]
|
Meyer, P.T., Hellwig, S. and Amtage, F., et al. (2011) Dual-biomarker imaging of regional cerebral amyloid load and neuronal activity in dementia with PET and 11C-labeled Pittsburgh compound B. Journal of Nuclear Medicine, 52, 393-400.
http://www.ncbi.nlm.nih.gov/pubmed/21321269
|
[24]
|
Adriaase, A., Sanz-Arigita, E. and Binnewijzend, M., et al. (2011) Molecular markers of Alzheimer’s disease pathology and their relationship with default mode network integrity. Journal of Alzheimer’s & Dementia, 7, S2-S3.
http://www.alzheimersanddementia.com/article/S1552-5260(11)00144-0/fulltext
|
[25]
|
Chételat, G., Villemagne, V.L., Pike, K.E., Ellis, K.A., Ames, D., Masters, C.L. and Rowe, C.C. (2012) Relationship between memory performance and β-amyloid deposition at different stages of Alzheimer’s disease. Neurodegenerative Diseases, 10, 141-144.
http://www.ncbi.nlm.nih.gov/pubmed/22301812
|
[26]
|
Holmes, C., Boche, D. and Wilkinson, D., et al. (2008) Long-term effects of Abeta42 immunisation in Alzheimer’s disease: Follow-up of a randomised, placebocontrolled phase I trial. The Lancet, 372, 216-223.
http://www.ncbi.nlm.nih.gov/pubmed/18640458?dopt=Abstract
|
[27]
|
Morel, F. (1950) An apparently dyshoric and topical angiopathy. Monatsschrift for Psychiatrie Neurologie, 120, 352-357. http://www.ncbi.nlm.nih.gov/pubmed/14806299
|
[28]
|
Maksimovich, I.V. (2009) Changes in angioarchetectonics of brain at Alzheimer’s disease. The Neurologic Bulletin, 2, 9-14. http://www.infamed.com/nb/2_2009_9-14.pdf
|
[29]
|
Maksimovich, I.V. (2011) Dyscirculatory angiopathy of Alzheimer’s type. Journal of Behavioral and Brain Science, 1, 57-68. doi:10.4236/jbbs.2011.12008
|
[30]
|
de la Torre, J.C. (1997) Hemodynamic consequences of deformed microvessels in the brain in Alzheimer’s disease. Annals of New York Acadmy Sciences, 26, 75-91.
http://www.ncbi.nlm.nih.gov/pubmed/9329682?dopt=Abstract
|
[31]
|
Skoog, I., Kalaria, R.N. and Breteler, M.M. (1999) Vascular factors and Alzheimer disease. Alzheimer Disease and Associated Disorders, 13, 106-114.
http://www.ncbi.nlm.nih.gov/pubmed?term=Skoog%20I%2C%20Kalaria%20R%20N%2C%20Breteler%20M.M.
|
[32]
|
Kalaria, R.N. (2000) Vascular factors in Alzheimer’s disease. New York Academy of Sciences, New York.
http://books.google.ru/books?id=jHZFAAAAYAAJ&hl=ru&source=gbs_book_similarbooks
|
[33]
|
Kivipelto, M., Helkala, E.L. and Laakso, M.P., et al. (2001) Midlife vascular risk factors and Alzheimer’s disease in later life: Longitudinal, population based study. British Medical Journal, 322, 1447-1451.
http://www.bmj.com/content/322/7300/1447
|
[34]
|
Kalaria, R.N. (2009) Neurodegenerative disease: Diabetes, microvascular pathology and Alzheimer disease. Nature Reviews. Neurology, 5, 305-306.
http://www.ncbi.nlm.nih.gov/pubmed/19498432
|
[35]
|
Di Iorio, A., Zito, M., Lupinetti, M. and Abate, G. (1999) Are vascular factors involved in Alzheimer’s disease? Facts and theories. Aging, 11, 345-352.
http://www.ncbi.nlm.nih.gov/pubmed/10738848
|
[36]
|
Mielke, M.M., Rosenberg, P.B., Tschanz, J.L. and Cook, L., et al. (2007) Vascular factors predict rate of progresssion in Alzheimer disease. Neurology, 6, 1850-1858.
http://www.neurology.org/content/69/19/1850.short
|
[37]
|
Helzner, E.P., Luchsinger, J.A., Scarmeas, N. and Cosentino, S., et al. (2009) Contribution of vascular risk factors to the progression in Alzheimer disease. Archives of Neurology, 66, 343-348. doi:10.1001/archneur.66.3.343
|
[38]
|
Weller, R.O., Subash, M., Preston, S.D., Mazanti, I. and Carare, R.O. (2008) Perivascular drainage of amyloidbeta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer’s disease. Brain Pathology, 18, 253-266.
http://www.ncbi.nlm.nih.gov/pubmed/18363936
|
[39]
|
Pezzini, A., Del Zotto, E., Volonghi, I., Giossi, A., Costa, P. and Padovani, A. (2009) Cerebral amyloid angiopathy: A common cause of cerebral hemorrhage. Current Medicinal Chemistry, 16, 2498-2513.
doi:10.2174/092986709788682047
|
[40]
|
de la Torre, J.C. and Stefano, G.B. (2000) Evidence that Alzheimer’s disease is a microvascular disorder: The role of constitutive nitric oxide. Brain Research Reviews, 34, 119-136. doi:10.1016/S0165-0173(00)00043-6
|
[41]
|
Kalaria, R.N. (2002) Small vessel disease and Alzheimer’s dementia: Pathological considerations. Cerebrovascular Diseases, 13, 48-52. doi:10.1159/000049150
|
[42]
|
de la Torre, J.C. (2002) Alzheimer disease as a vascular disorder: Nosological evidence. Stroke, 33, 1152-1162.
doi:10.1161/01.STR.0000014421.15948.67
|
[43]
|
Bell, R.D. and Zlokovic, B.V. (2009) Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer’s disease. Acta Neuropathologica, 118, 103-113.
http://www.ncbi.nlm.nih.gov/pubmed/19319544
|
[44]
|
Zlokovic, B.V. (2011) Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders. Nature Reviews. Neuroscience, 3, 723-738.
http://www.ncbi.nlm.nih.gov/pubmed/22048062
|
[45]
|
De la Torre, J.C. (2012) A turning point for Alzheimer’s disease? Biofactors, 38, 78-83. doi:10.1002/biof.200
|
[46]
|
Dhikav, V. and Anand, K.S. (2012) Are vascular factors linked to the development of hippocampal atrophy in Alzheimer’s disease? Journal of Alzheimer’s disease, 32, 711-718. http://www.ncbi.nlm.nih.gov/pubmed/22850312
|
[47]
|
Baloiannis, S.J. and Baloiannis, I.S. (2012) The vascular factor in Alzheimer’s disease: A study in Golgi technique and electron microscopy. Journal of the Neurological Sciences, 322, 117-121.
http://www.jns-journal.com/article/S0022-510X(12)00344-9/abstract
|
[48]
|
Sagare, A.P., Bell, R.D. and Zlokovic, B.V. (2012) Neurovascular defects and faulty amyloid-β vascular clearance in Alzheimer’s disease. Journal of Alzheimer’s disease, 2, a011452.
http://www.ncbi.nlm.nih.gov/pubmed/22751174
|
[49]
|
Kalaria, R.N., Akinyemi, R. and Ihara, M. (2012) Does vascular pathology contribute to Alzheimer changes? Journal of the Neurological Sciences, 322, 141-147.
http://www.ncbi.nlm.nih.gov/pubmed/22884479
|
[50]
|
Kalaria, R. (2012) The neuropathology of vascular cognitive disorders. Journal of Alzheimer’s & Dementia, 8, P727. doi:10.1016/j.jalz.2012.05.1958
|
[51]
|
Maksimovich, I.V. and Polyaev, Yu.A. (2010) The importance of early diagnosis of dyscircular angiopathy of Alzheimer’s type in the study of heredity of Alzheimer’s disease. Journal of Alzheimer’s & Dementia, 6, e43.
http://www.alzheimersanddementia.com/article/S1552-5260(10)02325-3/fulltext
|
[52]
|
Maksimovich, I.V. (2012) The tomography dementia rating scale (TDR)—The rating scale of Alzheimer’s disease stages. Health, 4, 712-719.
http://www.scirp.org/journal/PaperInformation.aspx?paperID=23257
|
[53]
|
Maksimovich, I.V. (2012) Vascular factors in Alzheimer’s disease. Health, 4, 735-742.
http://www.scirp.org/journal/PaperInformation.aspx?paperID=23274
|
[54]
|
Maksimovich, I.V. (2012) Endovascular application of low-energy laser in the treatment of dyscirculatory angiopathy of Alzheimer’s type. Journal of Behavioral and Brain Science, 2, 67-81. doi:10.4236/jbbs.2012.21008
|
[55]
|
Burton, E.J., Barber, R., Mukaetova-Ladinska, E.B., Robson, J., Perry, R.H., Jaros, E., Kalaria, R.N. and O’Brien, T.J. (2009) Medial temporal lobe atrophy on MRI differentiates Alzheimer’s disease from dementia with lewy bodies and vascular cognitive impairment: A prospective study with pathological verification of diagnosis. Brain, 132, 195-203.
http://www.ncbi.nlm.nih.gov/pubmed/19022858
|
[56]
|
World Alzheimer’s Report 2012.
http://www.alz.org/documents_custom/world_report_2012_final.pdf
|